This study investigates the effects of topical ophthalmic prednisolone (steroid) and diclofenac (nonsteroidal anti-inflammatory drug) on diabetes mellitus regulation in client-owned dogs.

This study investigates a new therapeutic target (valosin-containing protein) for dogs with lymphoma.

This fellowship investigates genetic lesions in canine mast cell tumors using cytogenetic and expression analysis.

This fellowship study investigates how incorporating cooked dry bean powders into a canine kibble diet alters inflammation and metabolism and thereby reduces the risk of obesity and potentially of cancer.

This study will use high throughput DNA sequencing methods to characterize the bacteria found on mammalian companion animals and their human household members, with an emphasis on methicillin-resistant Staphylococcus species.

This study investigates the therapeutic relevance of targeting the Wnt signaling pathways in canine malignant melanoma.

The aim of this study is to discover drugs that will work against cancer stem cells of an insulin-producing endocrine pancreatic tumor (insulinoma), thereby improving the prognosis of dogs suffering from insulinoma.

This pilot study will determine the dose and schedule of rapamycin, a promising new adjunct cancer drug.

This study will evaluate dogs with heart disease for a common genetic variant to determine whether this variant affects their ability to respond to heart medications.

This study investigates better postsurgical pain-management strategies for dogs after castration.